A randomized trial of oral vancomycin in neutropenic patients.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003091:Colistin / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000150:complications*; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy*; D009761:Nystatin / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy; D014640:Vancomycin / Q000008:administration & dosage / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D005839:Gentamicins; D009761:Nystatin; D014640:Vancomycin; D003091:Colistin